English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/37433
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Di-d-fructose Dianhydride-Enriched Caramels: Effect on Colon Microbiota, Inflammation, and Tissue Damage in Trinitrobenzenesulfonic Acid-Induced Colitic Rats

AuthorsArribas, Belén; Suárez-Pereira, Elena ; Ortiz-Mellet, Carmen; García-Fernández, José Manuel; Buttersack, Christoph; Rodríguez Cabezas, María Elena; Garrido Mesa, Natividad; Bailon, Elvira; Guerra Hernández, Eduardo; Zarzuelo Zurita, Antonio; Gálvez Peralta, Juan Julio
KeywordsCaramel
D-fructose
di-D-fructose dianhydrides
Fructooligosaccharides
Inflammatory bowel disease
TNBS rat colitis
Prebiotic
Issue Date28-Apr-2010
PublisherAmerican Chemical Society
CitationJournal of Agricultural and Food Chemistry 58(10): 6476-6484 (2010)
AbstractIn the present study we describe the preparation and chemical characterization of a caramel with a high (70%) content of difructose dianhydrides (DFAs) and glycosylated derivatives (DFAs). This product was obtained by thermal activation (90 °C) of highly concentrated (90% w/v) aqueous d-fructose solutions using the sulfonic acid ion-exchange resin Lewatit S2328 as caramelization catalyst. DFAs represent a unique family of cyclic fructans with prebiotic properties already present in low proportions (<15%) in commercial caramel. We report the antiinflammatory activity of the new DFA-enriched caramel in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis, an experimental model that resembles human inflammatory bowel disease (IBD), and compare its effects with those obtained with a commercial sucrose caramel and with linear fructooligosaccharides (FOS). For this purpose, the effects on colon tissue damage, gut microbiota, short-chain fatty acid (SCFAs) production, and different inflammatory markers were evaluated. The administration of DFA-enriched caramel to colitic rats showed intestinal antiinflammatory effect, as evidenced macroscopically by a significant reduction in the extent of the colonic damage induced by TNBS. This effect was similar to that obtained with FOS in the same experimental settings, whereas commercial caramel was devoid of any significant antiinflammatory effect. The beneficial effect was associated with the inhibition of the colonic levels of the proinflammatory cytokines, tumor necrosis factor α (TNF α) and interleukin 1β (IL-1β), and the reduction in colonic myeloperoxidase (MPO) activity and inducible nitric oxide synthase (iNOS) expression. The DFA-enriched caramel also promoted a more favorable intestinal microbiota, increasing lactobacilli and bifidobacteria counts as well as inducing higher concentrations of SCFAs in the luminal colonic contents. These results reinforce the concept of DFAs and glycosyl-DFAs as dietary beneficial compounds with prebiotic properties and suggest that the novel DFA-enriched caramel here reported may be an interesting candidate to be explored for the dietary treatment of human IBD.
Description9 páginas, 8 figuras, 3 tablas.
Publisher version (URL)http://dx.doi.org/10.1021/jf100513j
URIhttp://hdl.handle.net/10261/37433
DOI10.1021/jf100513j
ISSN0021-8561
Appears in Collections:(IIQ) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.